HIV infection and the risk of diabetes mellitus

AIDS

Volumn 23, Issue 10, 2009, Pages 1227-1234

  Butt, Adeel A ^a,b,g   McGinnis, Kathleen ^b   Rodriguez Barradas, Maria C ^c   Crystal, Stephen ^d   Simberkoff, Michael ^b   Goetz, Matthew Bidwell ^e   Leaf, David ^e   Justice, Amy C ^f  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d RUTGERS UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f YALE UNIVERSITY   (United States)

^g School of Medicine and Public Health ^*  (United States)

Author keywords

Antiretroviral therapy; Diabetes; HCV; HIV; Risk

Indexed keywords

GLUCOSE; INSULIN DERIVATIVE; ORAL ANTIDIABETIC AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTIVIRAL THERAPY; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MINORITY GROUP; MIXED INFECTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

EID: 67651102707     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32832bd7af     Document Type: Article

References (29)

1. Goulet JL, Fultz SL, McGinnis KA, Justice AC. Relative prevalence of comorbidities and treatment contraindications in HIV- mono-infected and HIV/HCV-co-infected veterans. AIDS 2005;19 (Suppl 3):S99-S105.
2. Goulet JL, Fultz SL, Rimland D, Butt A, Gibert C, Rodriguez- Barradas M, et al. Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis 2007;45:1593-1601.
3. Kilbourne AM, Justice AC, Rabeneck L, Rodriguez-Barradas M, Weissman S. General medical and psychiatric comorbidity among HIV-infected veterans in the post-HAART era. J Clin Epidemiol 2001;54 (Suppl 1):S22-S28.
4. Butt AA, Fultz SL, Kwoh CK, Kelley D, Skanderson M, Justice AC. The risk of diabetes in HIV infected Veterans in the pre and post-HAART era and the role of hepatitis C virus co-infection. Hepatology 2004;40:115-119.
5. Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med 2005;165:1179-1184.
6. Tien PC, Schneider MF, Cole SR, Levine AM, Cohen M, Deho- vitz J, et al. Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study. AIDS 2007;21:1739-1745.
7. Brar I, Shuter J, Thomas A, Daniels E, Absalon J. A comparison of factors associated with prevalent diabetes mellitus among HIV-infected antiretroviral-naive individuals versus individuals in the National Health and Nutritional Examination Survey cohort. J Acquir Immune Defic Syndr 2007;45:66-71.
8. Visnegarwala F, Chen L, Raghavan S, Tedaldi E. Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection. J Infect 2005; 50:331-337.
9. Ledergerber B, Furrer H, Rickenbach M, Lehmann R, Elzi L, Hirschel B, etal. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study. Clin Infect Dis 2007; 45:111-119.
10. Yoon C, Gulick RM, Hoover DR, Vaamonde CM, Glesby MJ. Case-control study of diabetes mellitus in HIV-infected patients. J Acquir Immune Defic Syndr 2004;37:1464-1469.
11. Jain MK, Aragaki C, Fischbach L, Gibson S, Arora R, May L, etal. Hepatitis C is associated with type 2 diabetes mellitus in HIV- infected persons without traditional risk factors. HIV Med 2007;8:491-497.
12. Justice AC, Landefeld CS, Asch SM, Gifford AL, Whalen CC, Covinsky KE. Justification for a new cohort study of people aging with and without HIV infection. J Clin Epidemiol2001;54 (Suppl 1):S3-S8.
13. Justice AC, ErdosJ, Brandt C, Conigliaro J, Tierney W, Bryant K. The Veterans Affairs Healthcare System: a unique laboratory for observational and interventional research. Med Care 2006;44 (8 Suppl 2):S7-S12.
14. FultzSL, Skanderson M, Mole LA, Gandhi N, Bryant K, Crystal S, et al. Development and verification of a 'virtual' cohort using the national VA health information system. Med Care 2006;44 (8 Suppl 2):S25-S30.
15. Justice AC, Dombrowski E, Conigliaro J, Fultz SL, Gibson D, Madenwald T, et al. Veterans Aging Cohort Study (VACS): overview and description. Med Care 2006; 44 (8 Suppl 2):S13-S24.
16. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med 1998; 158:1789-1795.
17. Gordon AJ, Maisto SA, McNeil M, Kraemer KL, Conigliaro RL, Kelly ME, et al. Three questions can detect hazardous drinkers. J Fam Pract 2001;50:313-320.
18. Miller DR, Safford MM, Pogach LM. Who has diabetes? Best estimates of diabetes prevalence in the department of Veterans Affairs based on computerized patient data. Diab Care 2004; 27 (suppl-2):B10-B21.
19. Floris-MooreM, Howard AA, Lo Y, Schoenbaum EE, ArnstenJH, Klein RS. Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men. AIDS Patient Care STD 2007;21:479-491.
20. Alter MJ, Moyer LA. The importance of preventing hepatitis C virus infection among injection drug users in the United States. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18 (Suppl 1):S6-S10.
21. Mehta SH, Brancati FL, Strathdee SA, Pankow JS, Netski D, Coresh J, et al. Hepatitis C virus infection and incident type 2 diabetes. Hepatology 2003; 38:50-56.
22. de Larranaga GF, WingeyerSD, Puga LM, Alonso BS, Benetucci JA. Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV-HCV-coinfected patients under highly active antiretro- viral treatment. Eur J Clin Microbiol Infect Dis 2006; 25:98-103.
23. Maeno T, Okumura A, Ishikawa T, Kato K, Sakakibara F, Sato K, et al. Mechanisms of increased insulin resistance in non- cirrhotic patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 2003;18:1358-1363.
24. Lecube A, Hernandez C, Genesca J, Simo R. Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: a case-control study. Diab Care 2006; 29:1096-1101.
25. Yazicioglu G, Isitan F, Altunbas H, Suleymanlar I, Ozdogan M, Balci MK, et al. Insulin resistance in chronic hepatitis C. Int J Clin Pract 2004; 58:1020-1022.
26. Brown TT, Li X, Cole SR, Kingsley LA, Pallela FJ, Riddler SA, et al. Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study. AIDS 2005; 19:1375-1383.
27. De WS, Sabin CA, Weber R, et al. Incidence and risk factors for new onset diabetes mellitus in HIV infected patients: the D:A:D study. Diabetes Care 2008; 31 :1224-1229.
28. Cossarizza A, Moyle G. Antiretroviral nucleoside and nucleotide analogues and mitochondria. AIDS 2004;18:137-151.
29. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 2005; 307:384-387.